Muhammad Al-Hajj
2021
In 2021, Muhammad Al-Hajj earned a total compensation of $2.7M as Chief Scientific Officer at IO Biotech.
Compensation breakdown
| Non-Equity Incentive Plan | $76,274 |
|---|---|
| Option Awards | $2,340,785 |
| Salary | $259,001 |
| Other | $2,167 |
| Total | $2,678,227 |
Al-Hajj received $2.3M in option awards, accounting for 87% of the total pay in 2021.
Al-Hajj also received $76.3K in non-equity incentive plan, $259K in salary and $2.2K in other compensation.
Rankings
In 2021, Muhammad Al-Hajj's compensation ranked 4,875th out of 12,415 executives tracked by ExecPay. In other words, Al-Hajj earned more than 60.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,875 out of 12,415 | 61st |
Division Manufacturing | 2,039 out of 5,505 | 63rd |
Major group Chemicals And Allied Products | 862 out of 2,375 | 64th |
Industry group Drugs | 772 out of 2,096 | 63rd |
Industry Pharmaceutical Preparations | 551 out of 1,546 | 64th |
Source: SEC filing on April 14, 2022.
Al-Hajj's colleagues
We found two more compensation records of executives who worked with Muhammad Al-Hajj at IO Biotech in 2021.